A phase II randomized, double-blind, multicenter, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of three strengths of ad 452 in adult subjects with active rheumatoid arthritis

Sheitanov, Y; Povoroznyuk, V; Dimic, Aleksandar N; Bookbinder, S; George, M; Gauler, G; von, Hinuber U; Walker, D; Braun, Juergen; Fear, S; Fritchley, S; Tansley, R; Baker, H

Rezultati

eNauka > Rezultati > A phase II randomized, double-blind, multicenter, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of three strengths of ad 452 in adult subjects with active rheumatoid arthritis

Naziv:	A phase II randomized, double-blind, multicenter, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of three strengths of ad 452 in adult subjects with active rheumatoid arthritis
Autori:	Sheitanov, Y; Povoroznyuk, V; Dimic, Aleksandar N; Bookbinder, S; George, M; Gauler, G; von, Hinuber U; Walker, D; Braun, Juergen; Fear, S; Fritchley, S; Tansley, R; Baker, H;
Godina:	2007
Publikacija:	ANNALS OF THE RHEUMATIC DISEASES
ISSN:	0003-4967 Annals of the Rheumatic Diseases Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 66 str. 448-448
WoS-ID:	000253101101717
URI:	https://enauka.gov.rs/handle/123456789/796589
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.